1162P - Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
| Autor: | Moreno, V., Gil-Martin, M., Johnson, M., Aljumaily, R., Lopez Criado, P., Northfelt, D.W., Crittenden, M., Jabbour, S., Rosen, L., Garrido Lopez, P., Hervás Morón, A., Rietschel, P., Mohan, K.K., Li, J., Stankevich, E., Rowlands, T., Feng, M., Lowy, I., Fury, M.G. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|